Andreas Matusch

Andreas Matusch

Auto-generated profile, based on publicly available information

Andreas Matusch

Institute of Neuroscience and Medicine (INM-2), Forschungszentrum Jülich, Jülich, Germany

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2019 in Human Brain Mapping
Verified
Journal Article
Open access
PDF file
CLChanghong Li
Changhong Li
JFJudith Fronczek‐Poncelet
Judith Fronczek‐Poncelet
DLDenise Lange
Denise Lange
EHEva Hennecke
Eva Hennecke
TKTina Kroll
Tina Kroll
DEDavid Elmenhorst
David Elmenhorst
Sleep deprivation (SD) could amplify the temporal fluctuation of spontaneous brain activities that reflect different arousal levels using a dynamic functional connectivity (dFC) approach. Therefore, we intended to evaluate the test–retest reliability of dFC characteristics during rested wakefulness (RW), and to explore how the properties of these dynamic connectivity states were affected by extended durations of acute sleep loss (28/52 hr). We acquired resting‐state fMRI and neuropsychological datasets in two independent studies: (a) twice during RW and once after 28 hr of SD (n = 15) and (b) after 52 hr of SD and after 14 hr of recovery sleep (RS; n = 14). Sliding‐window correlations approach was applied to estimate their covariance matrices and corresponding three connectivity states were generated. The test–retest reliability of dFC properties demonstrated mean dwell time and fraction of connectivity states were reliable. After SD, the mean dwell time of a specific state, featured by strong subcortical–cortical anticorrelations, was significantly increased. Conversely, another globally hypoconnected state was significantly decreased. Subjective sleepiness and objective performances were separately positive and negative correlated with the increased and decreased state. Two brain connectivity states and their alterations might be sufficiently sensitive to reflect changes in the dynamics of brain mental activities after sleep loss.

1 February 2005 in NeuroImage
Verified
Journal Article
Closed access
PMPhilipp T. Meyer
Philipp T. Meyer
DEDavid Elmenhorst
David Elmenhorst
DBDirk Bier
Dirk Bier
MHMarcus H. Holschbach
Marcus H. Holschbach
AMAndreas Matusch
Andreas Matusch
ABAndreas Bauer
Andreas Bauer

1 October 2006 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
AMAndreas Matusch
Andreas Matusch
PMPhilipp T. Meyer
Philipp T. Meyer
DBDirk Bier
Dirk Bier
MHMarcus H. Holschbach
Marcus H. Holschbach
DWDirk Woitalla
Dirk Woitalla
ABAndreas Bauer
Andreas Bauer

10 January 2022 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
CBCláudia Régio Brambilla
Cláudia Régio Brambilla
TVTanja Veselinović
Tanja Veselinović
RRRavichandran Rajkumar
Ravichandran Rajkumar
JMJörg Mauler
Jörg Mauler
AMAndreas Matusch
Andreas Matusch
INIrene Neuner
Irene Neuner
Currently, the metabotropic glutamate receptor 5 (mGluR5) is the subject of several lines of research in the context of neurology and is of high interest as a target for positron-emission tomography (PET). Here, we assessed the feasibility of using [11C]ABP688, a specific antagonist radiotracer for an allosteric site on the mGluR5, to evaluate changes in glutamatergic neurotransmission through a mismatch-negativity (MMN) task as a part of a simultaneous and synchronized multimodal PET/MR-EEG study. We analyzed the effect of MMN by comparing the changes in nondisplaceable binding potential (BPND) prior to (baseline) and during the task in 17 healthy subjects by applying a bolus/infusion protocol. Anatomical and functional regions were analyzed. A small change in BPND was observed in anatomical regions (posterior cingulate cortex and thalamus) and in a functional network (precuneus) after the start of the task. The effect size was quantified using Kendall’s W value and was 0.3. The motor cortex was used as a control region for the task and did not show any significant BPND changes. There was a significant ΔBPND between acquisition conditions. On average, the reductions in binding across the regions were - 8.6 ± 3.2% in anatomical and - 6.4 ± 0.5% in the functional network (p ≤ 0.001). Correlations between ΔBPND and EEG latency for both anatomical (p = 0.008) and functional (p = 0.022) regions were found. Exploratory analyses suggest that the MMN task played a role in the glutamatergic neurotransmission, and mGluR5 may be indirectly modulated by these changes.

1 November 2020 in NeuroImage
Verified
Journal Article
Open access
JMJörg Mauler
Jörg Mauler
AHAlexander Heinzel
Alexander Heinzel
AMAndreas Matusch
Andreas Matusch
HHHans Herzog
Hans Herzog
INIrene Neuner
Irene Neuner
NSN. Jon Shah
N. Jon Shah
The use of hybrid PET/MR imaging facilitates the simultaneous investigation of challenge-related changes in ligand binding to neuroreceptors using PET, while concurrently measuring neuroactivation or blood flow with MRI. Having attained a steady state of the PET radiotracer using a bolus-infusion protocol, it is possible to observe alterations in ligand neuroreceptor binding through changes in distribution volumes. Here, we present an iterative procedure for establishing an administration scheme to obtain steady state [C-11]flumazenil concentrations in grey matter in the human brain. In order to achieve a steady state in the shortest possible time, the bolus infusion ratio from a previous examination was adapted to fit the subsequent examination. 17 male volunteers were included in the study. Boli and infusions with different weightings were given to the subjects and were characterised by kbol values from 74 min down to 42 min. Metabolite analysis was used to ascertain the value of unmetabolised flumazenil in the plasma, and PET imaging was used to assess its binding in the grey matter. The flumazenil timeactivity curves (TACs) in the brain were decomposed into activity contributions from pure grey and white matter and analysed for 12 vol of interest (VOIs). The curves highlighted a large variability in metabolic rates between the subjects, with kbol = 54.3 min being a reliable value to provide flumazenil equilibrium conditions in the majority of the VOIs and cases. The distribution volume of flumazenil in all 12 VOIs was determined.

16 January 2015 in Zeitschrift für Gastroenterologie
Verified
Journal Article
Closed access
RUR Uerlings
R Uerlings
SBSg Boaru
Sg Boaru
SWS Weiskirchen
S Weiskirchen
AZA Zimmermann
A Zimmermann
AMA Matusch
A Matusch
Ralf WeiskirchenRalf Weiskirchen
Ralf Weiskirchen
Background: The liver is sensitively prone to alterations in metal content and homeostasis. Most of its metabolic and catabolic functions depend on trace elements. Metals are either integral part of enzymes, cofactors, or directly serve as chemical catalysts. Therefore, a lack of trace elements can lead to organ failure or systemic illness. Conversely, excessive hepatic trace element deposition resulting from genetic disorders, intoxication, extensive dietary supply, or long-term parenteral nutrition cause hepatic inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Material and Methods: We have recently established novel LA-ICP-MS-based protocols allowing quantitative biometal imaging in human and murine livers or other specimens [1 – 4]. We now extended these studies and provide a multitude of other examples in which these protocols were applied for metal quantification in liver sections taken from clinical cases and experimental models of hepatic metal disorders. Results: Sample preparation and quantification strategies were optimized for application of LA-ICP-MS in daily routine. To evaluate these protocols we have measured clinical samples taken from patients suffering from various metal disorders (e.g. hemochromatosis and Wilson's disease). In addition, we demonstrate that LA-ICP-MS is an effective tool to image the dynamic changes of various metals and metalloids and their mutual influence on each other during initiation of acute phase response in the liver. Conclusions: In summary, we demonstrate that LA-ICP-MS is an innovative technique that allows accurate biometal imaging with high sensitivity, spatial resolution, specificity, and quantification ability in diagnostic and hepatology research. References cited: [1] M-M P et al. PLoS One 2013;8(3):e58702. [2] M-M P et al. Int J Mass Spectrom. 2013;354 – 355: 281 – 287. [3] Boaru SG et al. BMC Neurosci. 2014;15(1):98. [4] Boaru SG et al. J. Cell. Mol. Med., in press. Corresponding author: Weiskirchen, Ralf E-Mail: [email protected]